Biochimica et Biophysica Acta-Reviews on Cancer

Article	Citations
Tumour cell-induced platelet aggregation in breast cancer: Scope of metal nanoparticles	411
Modeling bladder cancer in the laboratory: Insights from patient-derived organoids	270
Microbial influence on triggering and treatment of host cancer: An intestinal barrier perspective	215
The interaction of SET and protein phosphatase 2A as target for cancer therapy	205
miRNAs and androgen deprivation therapy for prostate cancer	176
Reflections on drug resistance to KRAS inhibitors and gene silencing/editing tools for targeting mutant KRAS in cancer treatment	157
Uveal melanoma modeling in mice and zebrafish	130
VISTA as a context-dependent immune checkpoint: Implications for tumor immunity and autoimmune pathogenesis	111
ESR1 activating mutations: From structure to clinical application	109
TSPAN1, a novel tetraspanin member highly involved in carcinogenesis and chemoresistance	105
Progress and challenges of immunotherapy in triple-negative breast cancer	102
Is tumour-expressed aminopeptidase N (APN/CD13) structurally and functionally unique?	96
Advances in epigenetic modifications and cervical cancer research	92
Nutrition and dietary restrictions in cancer prevention	90
Decoding the role of FOXP3 in esophageal cancer: Underlying mechanisms and therapeutic implications	85
Long non-coding RNAs: Fundamental regulators and emerging targets of cancer stem cells	83
Insights into the role of connexins and specialized intercellular communication pathways in breast cancer: Mechanisms and applications	79
Epigenetic changes associated with Bacillus Calmette-Guerin (BCG) treatment in bladder cancer	79
Biomarkers in high grade serous ovarian cancer	74
Dual perspective on autophagy in glioma: Detangling the dichotomous mechanisms of signaling pathways for therapeutic insights	73
Mitochondrial metabolism in laryngeal cancer: therapeutic mechanisms and prospects	70
CCL20-CCR6 signaling in tumor microenvironment: Functional roles, mechanisms, and immunotherapy targeting	65
Extracellular vesicles in cancer therapy: Roles, potential application, and challenges	65
Transcription factors in glioblastoma – Molecular pathogenesis and clinical implications	64
Contribution of CXCR3-mediated signaling in the metastatic cascade of solid malignancies	60

Prostate cancer: Molecular aspects, consequences, and opportunities of the multifocal nature	57
Advances and prospects of mRNA vaccines in cancer immunotherapy	54
S100A8 and S100A9 in Cancer	53
In what area of biology has a “new” type of cell death been discovered?	52
Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting	51
Targeting lipid metabolism in cancer metastasis	51
Long non-coding RNAs: A view to kill ovarian cancer	48
Small non-coding RNAs and pancreatic ductal adenocarcinoma: Linking diagnosis, pathogenesis, drug resistance, and therapeutic potential	48
Recent insights into RNA m5C methylation modification in hepatocellular carcinoma	48
Prognostic features of the tumour microenvironment in oesophageal adenocarcinoma	48
Multifaceted roles of neutrophils in tumor microenvironment	47
Interleukin-21 as an adjuvant in cancer immunotherapy: Current advances and future directions	47
Targeting Cdc20 for cancer therapy	47
Multiple therapeutic approaches of glioblastoma multiforme: From terminal to therapy	46
Multiple impacts of Naa10p on cancer progression: Molecular functions and clinical prospects	46
Enhancing the anti-tumor response by combining DNA damage repair inhibitors in the treatment of solid tumors	46
Editorial Board	45
The interplay of obesity, microbiome dynamics, and innovative anti-obesity strategies in the context of endometrial cancer progression and therapeutic approaches	45
Nondiploid cancer cells: Stress, tolerance and therapeutic inspirations	45
Vagus innervation in the gastrointestinal tumor: Current understanding and challenges	44
Refinement of safety and efficacy of anti-cancer chemotherapeutics by tailoring their site-specific intracellular bioavailability through transporter modulation	44
An overview of BAP1 biological functions and current therapeutics	43
Current advances in comprehensive omics data mining for oncology and cancer research	43
Ubiquitination/de-ubiquitination: A promising therapeutic target for PTEN reactivation in cancer	43
Predictive and prognostic value of PIK3CA mutations in HER2-positive breast cancer treated with tyrosine kinase inhibitors: A systematic review and meta-analysis	43
Unveiling the potential of gene editing techniques in revolutionizing Cancer treatment: A comprehensive overview	43
Abnormal metabolism in hepatic stellate cells: Pandora's box of MAFLD related hepatocellular carcinoma	42
Intestinal multicellular organoids to study colorectal cancer	42
The Pleiotropic role, functions and targeted therapies of LIF/LIFR axis in cancer: Old spectacles with new insights	42
CD8+ T-cell exhaustion: Impediment to triple-negative breast cancer (TNBC) immunotherapy	41
Modulation of N-glycosylation in the PD-1: PD-L1 axis as a strategy to enhance cancer immunotherapies	41
Antibody-drug conjugates in HER-2 negative breast cancers with poor prognosis	41
Mesenchymal stem cells in glioblastoma therapy and progression: How one cell does it all	41
Epithelial-Mesenchymal Transition in Cancer: A Focus on Itraconazole, a Hedgehog Inhibitor	41
Implications of viral infection in cancer development	41
Focus on mast cells in the tumor microenvironment: Current knowledge and future directions	40
Interactions between cancer cells and tumor-associated macrophages in tumor microenvironment	39
Platinum-based systematic therapy in triple-negative breast cancer	39
Antibody-drug conjugates in breast cancer: Marching from HER2-overexpression into HER2-low	39
Cross talk between autophagy and oncogenic signaling pathways and implications for cancer therapy	39
Matrisomics: Beyond the extracellular matrix for unveiling tumor microenvironment	38
Cellular functions, molecular signalings and therapeutic applications: Translational potential of deubiquitylating enzyme USP9X as a drug target in cancer treatment	38
A role for RIO kinases in the crosshair of cancer research and therapy	38
Advances in clinical immunotherapy for gastric cancer	38
In vitro anticancer properties of anthocyanins: A systematic review	37
ASPORIN: A root of the matter in tumors and their host environment	37
Muscle-to-tumor crosstalk: The effect of exercise-induced myokine on cancer progression	36
Overview of splicing variation in ovarian cancer	35
New target DDR1: A “double-edged sword” in solid tumors	35
RUNX1 and cancer	35

The emerging roles of dual-specificity phosphatases and their specific characteristics in human cancer	35
Exosomal non-coding RNAs (ncRNAs) as potential biomarkers in tumor early diagnosis	34
Carbonic anhydrase IX: An atypical target for innovative therapies in cancer	32
USP7 - a crucial regulator of cancer hallmarks	32
Research progress on the regulatory role of lactate and lactylation in tumor microenvironment	31
Directing CAR T cells towards the tumor vasculature for the treatment of solid tumors	31
HOXA1, a breast cancer oncogene	31
Emerging strategies to overcome PARP inhibitors' resistance in ovarian cancer	31
A holistic view on c-Kit in cancer: Structure, signaling, pathophysiology and its inhibitors	31
Manipulating macrophage polarization in cancer patients: From nanoparticles to human chimeric antigen receptor macrophages	31
Colorectal cancer: Metabolic interactions reshape the tumor microenvironment	31
Exploring the gut microbiome: A potential biomarker for cancer diagnosis, prognosis, and therapy	30
Dual role of Snail1 as transcriptional repressor and activator	30
The microbiota-m6A-metabolism axis: Implications for therapeutic strategies in gastrointestinal cancers	30
Strategies for studying immune and non-immune human and canine mammary gland cancer tumour infiltrate	30
Taurine and cancer: Biological properties and multifaceted roles in cancer progression	30
Schwann cells and enteric glial cells: Emerging stars in colorectal cancer	30
Scientific and clinical relevance of non-cellular tumor microenvironment components in ovarian cancer chemotherapy resistance	29
Data-driven approaches to advance research and clinical care for pediatric cancer	29
Stress granules dynamics and promising functions in pancreatic cancer	29
A novel approach to reducing disparities in health outcomes by enhancing interpretation of cancer clinical trials for underrepresented patient groups	29
Interleukin-1 signaling in solid organ malignancies	29
Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma	29
New insight into the role of SMAD4 mutation/deficiency in the prognosis and therapeutic resistance of pancreatic ductal adenocarcinomas	28
From resistance to resilience: Uncovering chemotherapeutic resistance mechanisms; insights from established models	28
To kill a cancer: Targeting the immune inhibitory checkpoint molecule, B7-H3	28
Potentially diagnostic and prognostic roles of piRNAs/PIWIs in pancreatic cancer: A review	28
Role of F-box proteins in human upper gastrointestinal tumors	28
Keep your eyes peeled for long noncoding RNAs: Explaining their boundless role in cancer metastasis, drug resistance, and clinical application	28
Keratin 1 as a cell-surface receptor in cancer	28
Augmentation of the EPR effect by mild hyperthermia to improve nanoparticle delivery to the tumor	27
Consequence of distinctive expression of MUC2 in colorectal cancers: How much is actually bad?	27
Epigenetic regulation of cancer-associated fibroblast heterogeneity	27
Proteomics of post-translational modifications in colorectal cancer: Discovery of new biomarkers	27
SNARE proteins: Core engines of membrane fusion in cancer	26
Dietary sugar intervention: A promising approach for cancer therapy	26
Perspectives and mechanisms for targeting mitotic catastrophe in cancer treatment	26
A special subtype: Revealing the potential intervention and great value of KRAS wildtype pancreatic cancer	26
Artificial intelligence and allied subsets in early detection and preclusion of gynecological cancers	26
The clinical significance and correlative signaling pathways of paired box gene 9 in development and carcinogenesis	26
Reflecting on the cardiac toxicity in non-small cell lung cancer in the era of immune checkpoint inhibitors therapy combined with thoracic radiotherapy	25
Dual roles of human endogenous retroviruses in cancer progression and antitumor immune response	25
Epidermal growth factor receptor PROTACs as an effective strategy for cancer therapy: A review	25
Understanding the role of DNA methylation in colorectal cancer: Mechanisms, detection, and clinical significance	25
Improving DCIS diagnosis and predictive outcome by applying artificial intelligence	25
Research progress of mitochondria and cytoskeleton crosstalk in tumour development	25
Radiotherapy modulates autophagy to reshape the tumor immune microenvironment to enhance anti-tumor immunity in esophageal cancer	24
Spatiotemporal heterogeneity and clinical challenge of pancreatic neuroendocrine tumors	24
Tumoral heterogeneity in neuroblastoma	24
Overcoming therapeutic resistance in pancreatic cancer: Emerging opportunities by targeting BRCAs and p53	24
Expression and function of NF-Y subunits in cancer	24
Non-small cell lung cancer: Emerging molecular targeted and immunotherapeutic agents	24
The correlation between gut and intra-tumor microbiota and PDAC: Etiology, diagnostics and therapeutics	24
The neoantigens derived from transposable elements – A hidden treasure for cancer immunotherapy	24
Emerging roles of PIWI-interacting RNAs (piRNAs) and PIWI proteins in head and neck cancer and their potential clinical implications	24
Finding the junction between claudins and endometrial carcinoma	23
Histone deacetylase complexes: Structure, regulation and function	23
B7-H3 regulates anti-tumor immunity and promotes tumor development in colorectal cancer	23
Role of the intratumoral microbiome in tumor progression and therapeutics implications	23
A digital highway for data fluidity and data equity in precision medicine	23
The interplay between microbiome and host factors in pathogenesis and therapy of head and neck cancer	23
Editorial Board	23
Machine Learning in Epigenomics: Insights into Cancer Biology and Medicine	23
βIII-tubulin overexpression in cancer: Causes, consequences, and potential therapies	22
The signaling pathways regulated by KRAB zinc-finger proteins in cancer	22
Epigenetic therapy: Research progress of decitabine in the treatment of solid tumors	22
Enhancing immune checkpoint blockade therapy of genitourinary malignancies by co-targeting PMN-MDSCs	22
The potential of TRP channels as new prognostic and therapeutic targets against prostate cancer progression	22
CD95 (Fas) and CD95L (FasL)-mediated non-canonical signaling pathways	22
Clinical considerations of CDK4/6 inhibitors in triple-negative breast cancer	22
Changing landscape of anti-angiogenic therapy: Novel approaches and clinical perspectives	22
Editorial Board	22
Advances in glioma models using in vivo electroporation to highjack neurodevelopmental processes	22
Centrosome amplification in cancer and cancer-associated human diseases	22
Psychological intervention to treat distress: An emerging frontier in cancer prevention and therapy	22
Tumor microenvironment diversity and plasticity in cancer multidrug resistance	22
Advances in tuft cells, a chemosensory cell in sequential diseases of the pancreas	22
Roles of K(H)SRP in modulating gene transcription throughout cancer progression: Insights from cellular studies to clinical perspectives	22
Anoikis and NETosis in colorectal cancer liver metastasis: the relationship and perspectives	22
Thymic epithelial tumor medical treatment: A narrative review	21

Epigenetic mechanisms of cancer progression and therapy resistance in estrogen-receptor (ER+) breast cancer	21
The role of exosomes in the tumour microenvironment on macrophage polarisation	21
Decoding the role of intratumoral microbiota in gastric cancer	21
TERT promoter mutations in gliomas: Molecular roles in tumorigenesis, metastasis, diagnosis, prognosis, therapeutic targeting, and drug resistance	21
GSDM family and glioma	21
Molecular and immune pathobiology of human angiosarcoma	21
The role of TRIM25 in the occurrence and development of cancers and inflammatory diseases	20
Improving the efficacy of anti-EGFR drugs in GBM: Where we are going?	20
Protein induced by vitamin K absence or antagonist II: Experience to date and future directions	20
Therapeutic strategies of dual-target small molecules to overcome drug resistance in cancer therapy	20
Unveiling Cuproptosis: Mechanistic insights, roles, and leading advances in oncology	20
Odors and cancer: Current status and future directions	20
Clinical and Molecular Attributes and Evaluation of Pancreatic Cystic Neoplasm	20
Interstitial fluid pressure as an emerging biomarker in solid tumors	20
The comparison of pathogenic role and mechanism of Kallistatin and PEDF in tumors	20
Dietary and serum advanced glycation end-products and clinical outcomes in breast cancer	20
Cyclin-dependent kinases in DNA damage response	19
The progress of immune checkpoint therapy in primary liver cancer	19
Biological function, regulatory mechanism, and clinical application of mannose in cancer	19
Relevance of tumor microbiome in cancer incidence, prognosis, and its clinical implications in therapeutics	19
A review exploring the fusion of oncolytic viruses and cancer immunotherapy: An innovative strategy in the realm of cancer treatment	19
RNF43 and ZNRF3: Versatile regulators at the membrane and their role in cancer	19
Editorial Board	19
Cancer-associated fungi: An emerging powerful player in cancer immunotherapy	19
Mechanistic regulation of FOXO transcription factors in the nucleus	19
Comprehensive insights of etiological drivers of hepatocellular carcinoma: Fostering targeted nano delivery to anti-cancer regimes	19
Novel therapeutic approaches in GEP-NETs based on genetic and epigenetic alterations	19